IL-10’s role in cancer is complex, evidenced by its contribution to both immune suppression and stimulation within the FAP+ stromal compartments of diverse tumors such as NSCLC, PDAC, CRC, and RCC. This evidence concerns the gene IL10 and non-small cell lung carcinoma.